Tetanus is extraordinarily rare in the United States, with roughly 27 cases per year across the entire country over the past 15 years. Globally, however, the picture is starkly different: low-income countries still see thousands of cases annually, particularly among newborns and unvaccinated adults. That gap between wealthy, well-vaccinated nations and the rest of the world is one of the starkest in all of infectious disease, and the reasons behind it reveal as much about health infrastructure and conflict as they do about the bacterium itself.
U.S. Cases by the Numbers
Between 2009 and 2023, 402 tetanus cases and 37 associated deaths were reported across 47 states and Washington, D.C., according to the most recent CDC surveillance data. That works out to a mean annual incidence of about 0.08 cases per million people, a number so low that an average-sized U.S. city could go decades without seeing a single case.1PubMed Central. Tetanus Surveillance – United States, 2009-2023 The overall case-fatality rate among those with known outcomes was about 12%, with deaths concentrated among older adults.2Morbidity and Mortality Weekly Report. Tetanus Surveillance — United States, 2009–2023
To put that in perspective, you are far more likely to be struck by lightning in a given year than to develop tetanus in the United States. But the rarity is entirely a product of vaccination. Before widespread immunization campaigns in the mid-twentieth century, tetanus killed hundreds of Americans each year. The bacterium itself, Clostridium tetani, has not gone anywhere. Its spores live in soil, dust, and animal feces around the world, and they are essentially indestructible under normal environmental conditions. What changed is that nearly every American child now receives the full childhood vaccine series, and most adults have had at least one booster.
Who Gets Tetanus in the U.S. Today
The demographics of the handful of American tetanus cases tell a clear story about where immunity breaks down. About 62% of all cases over the 2009–2023 period occurred in males, and incidence was higher in men than women across nearly every age group below 65.1PubMed Central. Tetanus Surveillance – United States, 2009-2023 The one striking exception: women aged 80 and older had the highest tetanus incidence of any group, at 0.27 cases per million. That likely reflects a generational gap in vaccination, since routine childhood immunization was not universally implemented until the 1940s and 1950s, and women born before that era may never have been vaccinated at all.
Older adults are vulnerable for a second reason beyond missed childhood shots. A large population-based survey found that protective antibody levels dropped sharply with age, falling from nearly 88% among children aged 6 to 11 down to about 28% among people 70 and older. Most of the tetanus cases and deaths reported in 1989 and 1990 occurred in people aged 60 and above.3PubMed. A population-based serologic survey of immunity to tetanus in the United States Research on cellular immunity confirms the pattern: the immune system’s memory of the tetanus vaccine fades dramatically as a person ages, leaving older individuals increasingly susceptible even if they were vaccinated decades earlier.4PubMed Central. Aging and the immune response to tetanus toxoid: diminished frequency and level of cellular immune reactivity to antigenic stimulation The reassuring counterpoint is that older people who do follow a proper booster schedule can still mount a protective response.5PubMed. Tetanus and Pertussis vaccines: their usefulness in the aging population
Unvaccinated children represent the other high-profile risk group, though cases among them are vanishingly rare in the U.S. precisely because exemption rates remain low overall. When cases do appear, they make the medical literature as individual case reports, not as outbreaks. One widely discussed case involved a 10-year-old unvaccinated child in Texas who developed suspected tetanus and spent a month in the hospital with cardiovascular and pulmonary complications.6PubMed Central. Suspected tetanus in an unvaccinated pediatric patient Cases like these underscore that even in a country where tetanus is almost unheard of, the disease can still be severe when it does occur.
The Global Picture Looks Very Different
The near-disappearance of tetanus from the U.S. and other wealthy nations masks a much heavier global burden. A systematic analysis using Global Burden of Disease data found that while incidence and death rates fell worldwide between 1990 and 2019, low-income countries continued to bear the overwhelming majority of cases. In those settings, newborns were the highest-risk group, while in wealthy countries, the small number of cases that still occurred were concentrated among adults over 70.7International Journal of Infectious Diseases. Global epidemiology and burden of tetanus from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019
The geographic disparities are enormous. A more recent analysis focused on children under five found that in 1990, the lowest-income regions had incidence rates thousands of times higher than the wealthiest regions. By 2021, there had been dramatic improvement everywhere, but the gap persisted. Eastern Sub-Saharan Africa still had the highest rates among children, at roughly 6.6 cases per 100,000, while regions like East, Central, and South Asia had driven their rates essentially to zero. In the highest-income regions, the child mortality rate from tetanus was zero.8PubMed Central. Global analysis of tetanus incidence and mortality in children under 5 years: findings from the Global Burden of Disease Study 2021
The sheer scale of the historical toll is worth appreciating. Tetanus was one of the leading infectious killers of newborns in the developing world throughout the twentieth century. The progress since then, while incomplete, has been remarkable, driven primarily by vaccinating pregnant women and improving the conditions under which births take place.
Neonatal and Maternal Tetanus
Neonatal tetanus occurs when a newborn’s umbilical cord stump is contaminated with C. tetani spores, typically during delivery in unhygienic conditions. It was once so common in parts of Africa and South Asia that it accounted for a staggering proportion of infant deaths. Global neonatal tetanus deaths dropped from roughly 200,000 in 2000 to about 49,000 by 2013, thanks to a combination of vaccinating pregnant women, improving access to trained birth attendants, and running targeted vaccination campaigns for women of reproductive age in high-risk areas.9PubMed Central. Maternal and neonatal tetanus elimination: from protecting women and newborns to protecting all
The goal of eliminating maternal and neonatal tetanus has been achieved in most of the world, but as of the most recent reviews, 12 countries had still not reached the elimination threshold. These are not randomly distributed: they include Afghanistan, Central African Republic, Mali, Nigeria, Somalia, South Sudan, Sudan, and Yemen, among others. The common thread is not ignorance of the vaccine’s value but the practical impossibility of reaching populations amid armed conflict, displacement of health workers, destruction of health facilities, and competition with other disease outbreaks for scarce funding.10PubMed Central. Progress and barriers towards maternal and neonatal tetanus elimination in the remaining 12 countries: a systematic review
Gender-related factors add another layer. Research across 39 low- and middle-income countries found that women’s empowerment, measured through factors like decision-making autonomy and education, was associated with better uptake of maternal tetanus vaccination. The specific barriers differed from one country to another, which means no single fix works everywhere.11PubMed Central. Women’s Empowerment and Gender-Related Factors Associated with Maternal Tetanus Protection in 39 Low- and Middle-Income Countries
Why Tetanus Can Never Be Eradicated
Unlike smallpox or polio, tetanus will never be eradicated in the traditional sense. The bacterium lives in the environment, not just in human hosts, so you cannot break a chain of person-to-person transmission because there is no such chain. C. tetani spores persist in soil, manure, and dust for years. Any wound, even a minor one, that introduces spores into oxygen-poor tissue can lead to infection.
There is another critical feature that makes tetanus unique among vaccine-preventable diseases: surviving an infection does not make you immune. The toxin that causes all the damage operates at doses so tiny that the amount needed to kill a person is not enough to trigger an immune response. You can recover from tetanus and contract it again. Vaccination is the only path to immunity.12PubMed Central. Overuse of tetanus toxoid vaccine: a common but under-addressed issue in Nepal This means the disease can only be controlled, never eliminated, and control depends entirely on maintaining high vaccination rates indefinitely.
What the Toxin Actually Does
The severity of tetanus, even when cases are rare, warrants understanding what makes it so dangerous. The toxin produced by C. tetani is one of the most potent biological poisons known. It travels along nerves from the wound site to the spinal cord and brainstem, where it blocks the release of neurotransmitters that normally keep muscles from firing uncontrollably. With those chemical brakes removed, motor neurons become hyperactive, and the result is the sustained muscle rigidity and violent spasms that define the disease.13PubMed Central. Tetanus: Pathophysiology, Treatment, and the Possibility of Using Botulinum Toxin against Tetanus-Induced Rigidity and Spasms
Lockjaw, the classic symptom, is exactly what it sounds like: the jaw muscles clamp shut and the person cannot open their mouth. In generalized tetanus, spasms spread to the neck, back, and limbs. Severe cases can fracture bones from the force of the muscle contractions, compromise breathing, and cause cardiac instability. Even with modern intensive care, the case-fatality rate remains meaningful. In a study of tetanus patients in Mogadishu, Somalia, where access to advanced critical care is limited, about 14% of monitored patients died despite receiving vaccine, immunoglobulin, antibiotics, and supportive treatment.14PubMed Central. Tetanus Cases in Mogadishu-Somalia: A Tragic Disease Despite the Existence of a Century-Old Safe and Efficient Tetanus Vaccine That is roughly in line with the 12% case-fatality rate seen in U.S. surveillance, a reminder that even the best hospitals struggle with severe tetanus.
Diagnosis adds another complication. There is no blood test for tetanus. The diagnosis is made on clinical grounds, meaning a doctor recognizes the pattern of symptoms and exposure history. This can be difficult, especially in localized tetanus, where only the muscles near the wound are affected.15PubMed Central. Making an objective diagnosis of tetanus-utility of a simple neurophysiological test In countries where physicians rarely encounter the disease, misdiagnosis or delayed diagnosis is a real possibility.
How Long Does Vaccine Protection Last
A common question for anyone who has had their shots is whether the standard ten-year booster schedule is actually necessary. The evidence on this is more nuanced than the straightforward “get a booster every ten years” message suggests.
A cross-sectional analysis found that about 97% of the population was seropositive for tetanus, and that antibody levels declined with an estimated half-life of 14 years. Mathematical modeling based on those data predicted that 95% of people would remain protected for at least 30 years after their primary vaccination series without any additional boosters.16PubMed Central. Durability of Vaccine-Induced Immunity Against Tetanus and Diphtheria Toxins: A Cross-sectional Analysis A serosurvey of university students and at-risk workers found that ten years after the last dose, 95% still had protective antibody levels, and that people who had completed a full five-dose primary series maintained protective titers for up to 20 years without a booster.17PubMed Central. Tetanus vaccination, antibody persistence and decennial booster: a serosurvey of university students and at-risk workers
Not all populations behave the same way, however. A study from China found somewhat shorter protection windows, with antibody levels staying above the protective threshold for roughly nine years overall after vaccination, and duration varying by the number of doses received and by sex.18PubMed Central. Population waning trajectories of vaccine-induced tetanus immunity in Zhejiang, China These differences may reflect the specific vaccine products used, the timing of the primary series, or population-level factors.
The practical upshot is that if you completed the full childhood series and received a booster at some point in adulthood, you are very likely still protected even if it has been more than ten years. But if you are over 60, or if you are not sure whether you ever completed the full series, the case for staying current on boosters is stronger because the margin of safety narrows with age.
Booster Policies Vary by Country
There is no global consensus on how often tetanus boosters should be given. The U.S. recommends a booster every ten years throughout adulthood, typically as part of the Tdap or Td combination vaccine. But European countries vary widely in their approach. Italy still recommends a booster every ten years, while the United Kingdom does not systematically vaccinate after age 14, relying on the durability of the childhood series.19PubMed Central. New guidelines about tetanus vaccination schedules in Europe should be evaluated with caution Other countries fall somewhere in between, with boosters recommended at 25 and 65, or only with wound management.
This heterogeneity is not irrational. It reflects different interpretations of the same serological data and different tolerances for the very small residual risk of tetanus in a well-vaccinated population. Countries that have moved away from routine decennial boosters have not seen upticks in tetanus cases, which supports the view that the childhood series provides durable protection for most people. But the U.S. approach has the advantage of catching people who may have had incomplete primary series or who may fall through the cracks of the healthcare system.
Injection Drug Use as a Risk Factor
One risk group that receives relatively little public attention is people who inject drugs. An investigation of tetanus cases among injecting drug users in the United Kingdom found that most patients had injected heroin intramuscularly, subcutaneously, or had missed veins. Injection-site infections were common, and the majority presented with severe generalized tetanus.20Emerging Infectious Diseases. Tetanus in Injecting Drug Users, United Kingdom
The mechanism is straightforward. Skin-popping and intramuscular injection create the kind of deep, oxygen-poor tissue wounds where C. tetani spores thrive. Heroin itself, particularly black tar heroin, can be contaminated with soil-borne bacteria. And people who inject drugs are less likely to be current on their vaccinations or to seek prompt medical care for wound infections. In both the U.S. and the U.K., clusters of tetanus among drug users have prompted targeted public health responses, though reaching this population for vaccination remains difficult.
Tetanus in Animals
Humans are not the only species affected. Horses and sheep are actually more sensitive to the tetanus toxin than people are, while cattle, dogs, and cats show greater natural resistance.21PubMed Central. Tetanus in animals Equine tetanus is a well-known and feared condition in veterinary medicine, and routine tetanus vaccination is standard practice for horses in most countries. Dogs and cats occasionally develop tetanus, but it is uncommon enough that many veterinarians in developed countries never see a case.
The variation in species sensitivity is not fully understood but likely relates to differences in how the toxin binds to and travels within the nervous system of different animals. What all susceptible species share is the same fundamental problem: the toxin is produced by a ubiquitous soil bacterium, and any wound can serve as a point of entry. There is no prospect of clearing the environment of C. tetani, which is why vaccination remains the only reliable preventive strategy for humans and animals alike.